Is it time to stop treating subsets of DLBCL with R-CHOP? Journal Article
| Author: | Moskowitz, C. |
| Article Title: | Is it time to stop treating subsets of DLBCL with R-CHOP? |
| Abstract: | Correlative data evaluating BCL6 protein expression and outcome in the US intergroup phase 3 randomized study of R-CHOP versus CHOP demonstrate that CHOP chemotherapy without rituximab is ineffective in BCL6-negative DLBCL. |
| Keywords: | immunohistochemistry; cancer chemotherapy; cancer survival; protein expression; prednisone; clinical trial; review; doxorubicin; rituximab; methodology; protein bcl 2; cyclophosphamide; vincristine; b cell lymphoma; messenger rna; protein bcl 6; large cell lymphoma; drug tolerance; drug mixture |
| Journal Title: | Blood |
| Volume: | 107 |
| Issue: | 11 |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2006-06-01 |
| Start Page: | 4197 |
| End Page: | 4198 |
| Language: | English |
| DOI: | 10.1182/blood-2006-03-008995 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 2" - "Export Date: 4 June 2012" - "CODEN: BLOOA" - "Source: Scopus" |
